RT Journal Article
SR Electronic
T1 Clinical and Radiological Evaluations of COVID-19 Patients with Anosmia: Preliminary Report
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.20.20106633
DO 10.1101/2020.05.20.20106633
A1 Lechien, Jerome R.
A1 Michel, Justin
A1 Radulesco, Thomas
A1 Chiesa-Estomba, Carlos M.
A1 Vaira, Luigi A.
A1 De Riu, Giacomo
A1 Sowerby, Leigh
A1 Hopkins, Claire
A1 Saussez, Sven
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.20.20106633.abstract
AB Objective To investigate clinical and radiological features of olfactory clefts of patients with mild coronavirus disease 2019 (COVID-19).Methods Sixteen COVID-19 patients were recruited. The epidemiological and clinical data were extracted. Nasal complaints were assessed through the sino-nasal outcome test 22 (SNOT-22). Patients underwent psychophysical olfactory testing, olfactory cleft examination and CT-scan.Results Sixteen anosmic patients were included. The mean Sniffin’Sticks score was 4.6±1.7. The majority of patients had no endoscopical abnormality, with a mean olfactory cleft endoscopy score of 0.6±0.9. The olfactory clefts were opacified in 3 patients on the CT-scan. The mean radiological olfactory cleft score was 0.7±0.8. There were no significant correlations between clinical, radiological and psychophysical olfactory testing.Conclusion The olfactory cleft of anosmic COVID-19 patients is free regarding endoscopic examination and imaging. The anosmia etiology would be not related to edema of the olfactory cleft.Level of Evidence 4Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIJB-0M011-3137Funding StatementnoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available with corresponding author approval